InvestorsHub Logo
Followers 3
Posts 292
Boards Moderated 0
Alias Born 12/21/2022

Re: Tartiaboy post# 448

Wednesday, 08/23/2023 6:45:34 PM

Wednesday, August 23, 2023 6:45:34 PM

Post# of 569
Out licensing for non cancer indication will not bring substantial money to Aptose. They don't have any clinical data. Who is going to pay upfront? For Aptose, licensing would make sense only for all indications.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News